Terumo Blood and Cell Technologies’ Reveos Automated Whole Blood Processing System Receives the US FDA’s Clearance to Boost US Platelet Supply
- The US FDA cleared Reveos' automated whole blood processing system for commercial use in the US. The device can process whole blood into platelets and other components in one centrifugation cycle, eliminating some manual steps to separate platelets from the rest of the blood
- The device can help blood centers make the process of collecting platelets from blood donations more efficient, increasing availability for people who need them for treatment. The device also improves the platelet supply
- The system helps to reduce costs and improve overall efficiency by obtaining more blood products from the same number of donors. Reveos has the potential to reduce the working hours needed by laboratory staff by ~30%
Ref: Terumo Blood and Cell Technologies | Image: Terumo Blood and Cell Technologies
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at firstname.lastname@example.org
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at email@example.com.